NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Gastroenterology Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gastroenterology Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Pancreatitis



Chronic pancreatitis is inhibited by a degradation-sensitive anionic trypsinogen



August 7th, 2006

According to recent research from Germany, chronic pancreatitis is inhibited by a degradation-sensitive anionic trypsinogen.

"Chronic pancreatitis is a common inflammatory disease of the pancreas. Mutations in the genes encoding cationic trypsinogen (PRSS1) 1 and the pancreatic secretory trypsin inhibitor (SPINK1) 2 are associated with chronic pancreatitis.

"Because increased proteolytic activity owing to mutated PRSS1 enhances the risk for chronic pancreatitis, mutations in the gene encoding anionic trypsinogen (PRSS2) may also predispose to disease," wrote H. Witt and colleagues, University Hospital Berlin.

"Here we analyzed...


Source: Gastroenterology Week (2006-08-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login